Highlights and Quick Summary
- Net Profit Margin for the quarter ending September 30, 2022 was -56.08% (a -37.56% decrease compared to previous quarter)
- Year-over-year quarterly Net Profit Margin increased by 48.75%
- Annual Net Profit Margin for 2021 was -117.11% (a -88.59% decrease from previous year)
- Annual Net Profit Margin for 2020 was -1026.35% (a 360.27% increase from previous year)
- Annual Net Profit Margin for 2019 was -222.99% (a -54.52% decrease from previous year)
- Twelve month Net Profit Margin ending September 30, 2022 was -81.09% (a -21.24% decrease compared to previous quarter)
- Twelve month trailing Net Profit Margin decreased by -30.76% year-over-year
Trailing Net Profit Margin for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| -81.09% | -102.96% | -103.16% | -117.11% |
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Profit Margin of BioCryst Pharmaceuticals, Inc.
Most recent Net Profit Marginof BCRX including historical data for past 10 years.Interactive Chart of Net Profit Margin of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Net Profit Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -56.08% | -89.82% | -148.62% | – |
| 2021 | -37.7% | -143.44% | -86.47% | -337.29% | -117.11% |
| 2020 | -1506.3% | -755.74% | -1344.72% | -779.58% | -1026.35% |
| 2019 | -6.6% | -2117.86% | -2598.69% | -527.5% | -222.99% |
| 2018 | -1005.2% | -2035.56% | -147.64% | -648.31% | -490.25% |
| 2017 | -502.39% | -172.76% | -544.89% | -150.67% | -261.18% |
| 2016 | -50.13% | -148.5% | -340.11% | -473.69% | -209.25% |
| 2015 | -394.07% | -133.08% | 18.97% | -222.15% | -89.15% |
| 2014 | -214.32% | -269.64% | -999.25% | -293.15% | -332.08% |
| 2013 | -51.38% | -334.91% | -1482.58% | -126.79% | -173.72% |
| 2012 | -269.52% | -168.37% | -291.59% | -49.52% | -148.64% |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology